PetVivo Inc.

0.53
-0.06 (-10.77%)
At close: Mar 31, 2025, 10:07 AM

Company Description

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals.

Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses.

The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications.

PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

PetVivo Inc.
PetVivo  Inc. logo
Country United States
IPO Date Sep 8, 2014
Industry Medical - Devices
Sector Healthcare
Employees 20
CEO John Lai

Contact Details

Address:
5251 Edina Industrial Boulevard
Minneapolis, Minnesota
United States
Website https://www.petvivo.com

Stock Details

Ticker Symbol PETV
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001512922
CUSIP Number 716817408
ISIN Number US7168174081
Employer ID 99-0363559
SIC Code 3841

Key Executives

Name Position
John Lai Chief Executive Officer, President & Director
Garry N. Lowenthal Chief Financial Officer
April Boyce Vice President of Sales & Marketing
Gary DeMel Executive Vice President of Business Development
John F. Dolan General Counsel, Chief Business Development Officer & Secretary
Michael Eldred BA, MBA Commercialization & Operations Advisor and Executive Director
Randy Wenthold Chief Science Officer

Latest SEC Filings

Date Type Title
Mar 26, 2025 8-K Current Report
Mar 10, 2025 8-K Current Report
Feb 28, 2025 8-K Current Report
Feb 18, 2025 8-K Current Report
Feb 18, 2025 8-K Current Report
Feb 14, 2025 10-Q Quarterly Report
Feb 13, 2025 8-K Current Report
Feb 12, 2025 SCHEDULE 13G/A [Amend] Filing
Feb 11, 2025 SCHEDULE 13G/A [Amend] Filing
Feb 04, 2025 8-K Current Report